GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Impax Laboratories, Inc. (IPXL) [hlAlert]

Rating:
Neutral IPXL

Impax Laboratories, Inc. (IPXL) rated Neutral with price target $20 by UBS

Posted on: Thursday,  Sep 15, 2011  11:25 AM ET by UBS

Impax Laboratories, Inc. (NASDAQ:
IPXL) rated Neutral with price target $20 by UBS.

Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company. The Company is focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals, utilizing its controlled-release and other in-house development and formulation expertise. In the generic pharmaceuticals market, the Company focuses its efforts on controlled-release generic versions of selected brand-name pharmaceuticals covering a range of therapeutic areas. In the brand-name pharmaceuticals market, Impax is developing products for the treatment of central nervous system (CNS), disorders. Its brand-name product portfolio consists of development-stage projects to which it is applying its formulation and development expertise to develop differentiated, modified, or controlled-release versions of marketed drug substances. The Company operates in two segments: Global Pharmaceuticals Division (Global Division) and the Impax Pharmaceutical Division (Impax Division).

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/5/2014 2:25 PM Hold
None
29.32 30.00
as of 12/30/2011
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/7/2013 11:25 AM Hold
None
15.68 17.00
9/15/2011 11:25 AM Hold
None
18.50 20.00
4/15/2011 11:25 AM Hold
None
27.12 30.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy